Christensen Jeffrey E, Stencil Jennifer A, Reed Kurt D
Clinical Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin 54449, USA.
J Clin Microbiol. 2003 Aug;41(8):3790-800. doi: 10.1128/JCM.41.8.3790-3800.2003.
Bacteremia results in significant morbidity and mortality, especially among patient populations that are immunocompromised. Broad-spectrum antibiotics are administered to patients suspected to have bloodstream infections that are awaiting diagnosis that depends on blood culture analysis. Significant delays in identification of pathogens can result, primarily due to the dependence on growth-based identification systems. To address these limitations, we took advantage of terminal restriction fragment (TRF) length polymorphisms (T-RFLP) due to 16S ribosomal DNA (rDNA) sequence diversity to rapidly identify bacterial pathogens directly from positive blood culture. TRF profiles for each organism were determined by sizing fragments from restriction digests of PCR products derived from two sets of 16S rDNA-specific fluorescent dye-labeled primers. In addition, we created a TRF profile database (TRFPD) with 5899 predicted TRF profiles from sequence information representing 2860 different bacterial species. TRF profiles were experimentally determined for 69 reference organisms and 32 clinical isolates and then compared against the predicted profiles in the TRFPD. The predictive value of the profiles was found to be accurate to the species level with most organisms tested. In addition, identification of 10 different genera was possible with profiles comprising two or three TRFs. Although it was possible to identify Enterobacteriaceae by using a profile of three TRFs, the similarity of the TRF profiles of these organisms makes differentiation of species less reliable with the current method. The ability to rapidly (i.e., within approximately 8 h) identify bacteria from blood cultures has potential for reducing unnecessary use of broad-spectrum antibiotics and promoting more timely prescription of appropriate antibiotics.
菌血症会导致严重的发病和死亡,尤其是在免疫功能低下的患者群体中。对于疑似患有血流感染且正在等待依赖血培养分析进行诊断的患者,会使用广谱抗生素。主要由于依赖基于生长的鉴定系统,病原体鉴定可能会出现显著延迟。为了解决这些局限性,我们利用了由于16S核糖体DNA(rDNA)序列多样性导致的末端限制片段(TRF)长度多态性(T-RFLP),直接从阳性血培养物中快速鉴定细菌病原体。通过对来自两组16S rDNA特异性荧光染料标记引物的PCR产物进行限制性消化后的片段大小测定,确定每种生物体的TRF图谱。此外,我们创建了一个TRF图谱数据库(TRFPD),其中包含来自代表2860种不同细菌物种的序列信息的5899个预测TRF图谱。对69种参考生物体和32种临床分离株进行了TRF图谱的实验测定,然后与TRFPD中的预测图谱进行比较。发现大多数测试生物体的图谱预测值在物种水平上是准确的。此外,通过包含两个或三个TRF的图谱可以鉴定10个不同的属。虽然使用三个TRF的图谱可以鉴定肠杆菌科,但这些生物体的TRF图谱的相似性使得用当前方法区分物种的可靠性较低。能够快速(即大约8小时内)从血培养物中鉴定细菌,有可能减少广谱抗生素的不必要使用,并促进更及时地开具适当的抗生素处方。